Table 2 of Tiercy, Mol Vis 2010; 16:353-358. Table 2 of Tiercy, Mol Vis 2010; 16:353-358.
Table 2. HLA-DRB1 frequencies (generic DR types) in patients with VKH syndrome compared to patients with SO and to healthy controls.
| Allele |
VKH patient alleles (2n=188) |
SO patient alleles (2n=78) |
Control subject alleles (2n=224) |
VKH versus controls |
SO versus controls |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| number | % | number | % | number | % | OR | 95% CI | p-value† | OR | 95% CI | p-value† | |
| HLA-DRB1*01 | 4 | 2.1 | 1 | 1.3 | 4 | 1.8 | 1.20 | 0.30–4.85 | 1 | 0.71 | 0.08–6.49 | 1 |
| HLA-DRB1*03 | 10 | 5.3 | 8 | 10.3 | 12 | 5.4 | 0.99 | 0.42–2.35 | 1 | 2.02 | 0.79–5.14 | 0.18 |
| HLA-DRB1*04 | 38 | 20.2 | 11 | 14.1 | 23 | 10.3 | 2.21 | 1.27–3.87 | 0.005# | 1.44 | 0.66–3.10 | 0.41 |
| HLA-DRB1*07 | 30 | 16.0 | 7 | 9.0 | 40 | 17.9 | 0.87 | 0.52–1.47 | 0.69 | 0.45 | 0.19–1.06 | 0.07 |
| HLA-DRB1*08 | 5 | 2.7 | 7 | 9.0 | 9 | 4.0 | 0.65 | 0.22–1.98 | 0.59 | 2.36 | 0.85–6.56 | 0.14 |
| HLA-DRB1*09 | 2 | 1.1 | 2 | 2.6 | 0 | 0.0 | 6.02 | 0.29–126 | 0.21 | 14.7 | 0.70–309 | 0.07 |
| HLA-DRB1*10 | 15 | 8.0 | 9 | 11.5 | 24 | 10.7 | 0.72 | 0.37–1.42 | 0.40 | 1.09 | 0.48–2.45 | 0.84 |
| HLA-DRB1*11 | 6 | 3.2 | 2 | 2.6 | 5 | 2.2 | 1.44 | 0.43–4.81 | 0.56 | 1.15 | 0.22–6.07 | 1 |
| HLA-DRB1*12 | 6 | 3.2 | 2 | 2.6 | 12 | 5.4 | 0.58 | 0.21–1.58 | 0.34 | 0.47 | 0.10–2.13 | 0.53 |
| HLA-DRB1*13 | 16 | 8.5 | 3 | 3.8 | 21 | 9.4 | 0.90 | 0.46–1.78 | 0.86 | 0.39 | 0.11–1.33 | 0.15 |
| HLA-DRB1*14 | 19 | 10.1 | 4 | 5.1 | 15 | 6.7 | 1.57 | 0.77–3.18 | 0.22 | 0.75 | 0.24–2.34 | 0.79 |
| HLA-DRB1*15 | 36 | 19.1 | 22 | 28.2 | 59 | 26.3 | 0.66 | 0.41–1.06 | 0.10 | 1.10 | 0.62–1.95 | 0.77 |
| HLA-DRB1*16 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 3.59 | 0.15–88.7 | 0.46 | n.a. | n.a. | n.a. |